Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia,Hirsutism,and Acne

Abstract

French

Background:

The androgen receptor (AR) is a structurally conserved member of the nuclear receptor superfamily. The amino-terminal domain is required for transcriptional activation and contains a region of polyglutamine encoded by CAG trinucleotide repeats. In humans, the number of CAG repeats is polymorphic. Expansion of CAG repeats in the AR has clinical implications for human disease.

Objective:

Androgens influence androgenetic alopecia (AGA), hirsutism, and acne; the polymorphisms in CAG repeat length may affect the clinical course of patients with these cutaneous disorders. The purpose of this study is to test for an association between these disorders and CAG repeat length.

Methods:

We analyzed normal lymphocyte genomic DNA from a total of 48 men and 60 women. The CAG repeat region of the AR was amplified by polymerase drain reaction (PCR) and the products were sized on polyacrylamide gels.

Results:

In normal men and women controls, a range of 12 to 29 trinucleotide repeats was found, with men having 22 ± 4 (M ± SD), women 21 ± 3. Men with AGA had 19 ± 3, whereas women with AGA had 17 ± 3. Men with acne had 21 ± 3, whereas women had 20 ± 3; men with AGA and acne had 18 ± 4; and women with hirsutism had 16 ± 3. Women with a combination of at least two disorders also had 16 ± 3 trinucleotide repeats.

Conclusion:

Shorter CAG-repeat lengths may be associated with the development of androgen-mediated skin disorders in men and women. These data suggest that CAG-repeat length in AR may affect androgen mediated gene expression in hair follicles and sebaceous glands in men and women with these androgenic skin disorders.

Get full access to this article

View all access options for this article.

References

Sawaya

Price

. Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997; 109:296–300.

Mangelsdorf

Thummel

Beato

. The nuclear receptor superfamily: The second decade. Cell 1995; 83:835–839.

Hardy

Scher

Bogenreider

. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset. J Clin Endocrin Metab 1996; 81:4400–4405.

Sawaya

. Androgen action at the cellular level. In: Redmond

, ed. Androgenic disorders. New York: Raven Press, 1995: 35–47.

Tilley

Marcelli

McPhaul

. Recent studies on the androgen receptor: New insights into old questions. Mol Cell Endocrinol 1990; 68:C7–C10.

Kremer

Pritchard

Lynch

. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(GGG)n. Science 1991; 252:1711–1714.

Verkerk

AJMH

Pieretti

Sutcliffe

. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65:905–914.

Pizzuti

Fenwick

Jr . An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992; 255:1256–1258.

La Spada

Wilson

Lubahn

. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352:77–91.

10.

Orr

Chung

Banfi

. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993; 4:221–226.

11.

Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72:971–983.

12.

Koide

Ikeucki

Onodera

. Expansion of an unstable trinucleotide CAG repeat in hereditary dentatorubral-palli-doluysian atrophy (DR-PLA). Nat Genet 1994; 6:9–13.

13.

Nagatuchi

Yanagisawa

Sato

. Dentatorubral and pallidoluysian atrophy: Expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994; 6:14–18.

14.

La Spada

Paulson

Fischbeck

. Trinucleotide repeat expansion in neurological disease. Ann Neurol 1994; 36:814–822.

15.

Chamberlain

Driver

Miesfield

. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181–3186.

16.

Coetzee

Ross

. Prostate cancer and the androgen receptor. J Natl Cancer Inst 1994; 86:872–873.

17.

Legro

Shahbahrami

Lobo

Kovacs

. Size polymorphisms of the androgen receptor among female hispanics and correlation with androgenic characteristics. Obstet Gynecol 1994; 83:701–706.

18.

Nanus

Mentle

Matzer

. Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol 1990; 143:175–178.

19.

Edwards

Hammond

Jin

. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 1992; 12:241–253.

20.

McPhaul

Marcelli

Tilley

. Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest 1991; 87:1413–1421.

21.

Caskey

Pizzuti

Jing-Hui

. Triplet repeat mutations in human disease. Science 1992; 256:784–788.

22.

Mowszowicz

Melanitou

Doukani

. Androgen binding capacity and 5α-reductase activity in pubic skin fibroblasts from hirsute patients. J Clin Endocrinol Metab 1983; 56:1209–1213.

23.

Labri

Belanger

Cusan

Candas

. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: Intra-crinology. J Clin Endocrinol Metab 1997; 82:2403–2409.

24.

Deslypere

Young

Wilson

McPhaul

. Testosterone and 5α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol Cell Endocrinol 1992; 88:15–22.